| Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis LD Jacobs, DL Cookfair, RA Rudick, RM Herndon, JR Richert, ... Annals of Neurology: Official Journal of the American Neurological …, 1996 | 3133 | 1996 |
| Natalizumab plus interferon beta-1a for relapsing multiple sclerosis RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... New England Journal of Medicine 354 (9), 911-923, 2006 | 1738 | 2006 |
| Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) RHB Benedict, D Cookfair, R Gavett, M Gunther, F Munschauer, N Garg, ... Journal of the International Neuropsychological Society 12 (4), 549-558, 2006 | 1002 | 2006 |
| Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change RHB Benedict, E Wahlig, R Bakshi, I Fishman, F Munschauer, ... Journal of the neurological sciences 231 (1-2), 29-34, 2005 | 802 | 2005 |
| Thalamic atrophy and cognition in multiple sclerosis MK Houtchens, RHB Benedict, R Killiany, J Sharma, Z Jaisani, B Singh, ... Neurology 69 (12), 1213-1223, 2007 | 628 | 2007 |
| Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden RHB Benedict, B Weinstock-Guttman, I Fishman, J Sharma, CW Tjoa, ... Archives of neurology 61 (2), 226-230, 2004 | 510 | 2004 |
| Eight-year follow-up study of brain atrophy in patients with MS E Fisher, RA Rudick, JH Simon, G Cutter, M Baier, JC Lee, D Miller, ... Neurology 59 (9), 1412-1420, 2002 | 464 | 2002 |
| Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis JH Simon, LD Jacobs, M Campion, K Wende, N Simonian, DL Cookfair, ... Annals of neurology 43 (1), 79-87, 1998 | 452 | 1998 |
| Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study B Banwell, L Krupp, J Kennedy, R Tellier, S Tenembaum, J Ness, ... The Lancet Neurology 6 (9), 773-781, 2007 | 435 | 2007 |
| Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test BA Parmenter, B Weinstock-Guttman, N Garg, F Munschauer, ... Multiple Sclerosis Journal 13 (1), 52-57, 2007 | 435 | 2007 |
| Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis S Batista, R Zivadinov, M Hoogs, N Bergsland, M Heininen-Brown, ... Journal of neurology 259, 139-146, 2012 | 422 | 2012 |
| Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis RHB Benedict, JM Bruce, MG Dwyer, N Abdelrahman, S Hussein, ... Archives of neurology 63 (9), 1301-1306, 2006 | 419 | 2006 |
| Validity of the beck depression inventory-fast screen in multiple sclerosis RHB Benedict, I Fishman, MM McClellan, R Bakshi, B Weinstock-Guttman Multiple Sclerosis Journal 9 (4), 393-396, 2003 | 415 | 2003 |
| Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis MP Sanfilipo, RHB Benedict, B Weinstock-Guttman, R Bakshi Neurology 66 (5), 685-692, 2006 | 414 | 2006 |
| The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL PA Calabresi, G Giovannoni, C Confavreux, SL Galetta, E Havrdova, ... Neurology 69 (14), 1391-1403, 2007 | 411 | 2007 |
| Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis RA Rudick, NA Simonian, JA Alam, M Campion, JO Scaramucci, W Jones, ... Neurology 50 (5), 1266-1272, 1998 | 386 | 1998 |
| Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis BAC Cree, O Khan, D Bourdette, DS Goodin, JA Cohen, RA Marrie, ... Neurology 63 (11), 2039-2045, 2004 | 363 | 2004 |
| Gut microbiota in early pediatric multiple sclerosis: a case− control study H Tremlett, DW Fadrosh, AA Faruqi, F Zhu, J Hart, S Roalstad, J Graves, ... European journal of neurology 23 (8), 1308-1321, 2016 | 360 | 2016 |
| Reliable screening for neuropsychological impairment in multiple sclerosis RHB Benedict, D Cox, LL Thompson, F Foley, B Weinstock-Guttman, ... Multiple Sclerosis Journal 10 (6), 675-678, 2004 | 355 | 2004 |
| Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test AS Drake, B Weinstock-Guttman, SA Morrow, D Hojnacki, FE Munschauer, ... Multiple Sclerosis Journal 16 (2), 228-237, 2010 | 327 | 2010 |
